Home / FRX.TO : TSX

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does FRX.TO make money? Does FRX.TO have pricing power? What's the Earnings Whisper? Will FRX.TO profit more as the business scales? What is FRX.TO's management track record? Is FRX.TO's current price justified?

Fennec Pharmaceuticals Inc.

CAD 17.1 +$6.69 (+64.27%)

TSX · 10 Sep 2026 20:10 UTC

Previous Close

CAD 17.1

Day Range

CAD 17.1 - CAD 17.1

Year Range

CAD 7.59CAD 17.64

Market Cap

594M

AVG Volume

1.05K

Trailing/Forward PE

-83.92/18.65

PEG ratio

-0.36

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

Toronto Stock Exchange

Revenue (USD)

FRX.TO Revenue (USD) by year
Period	Revenue (USD)
2025	44.85M
2024	47.54M
2023	21.25M
2022	1.53M
2021	0
2020	170K
2019	0
2018	0
2017	0
2016	0

Net Income (USD)

FRX.TO Net Income (USD) by year
Period	Net Income (USD)
2025	-10.18M
2024	-436K
2023	-16.07M
2022	-23.79M
2021	-17.35M
2020	-18.11M
2019	-12.78M
2018	-9.89M
2017	-7.05M
2016	-2.79M

Operating Income (USD)

FRX.TO Operating Income (USD) by year
Period	Operating Income (USD)
2025	-6.79M
2024	2.57M
2023	-12.77M
2022	-22.59M
2021	-17.22M
2020	-17.89M
2019	-13.01M
2018	-10.41M
2017	-6.95M
2016	-2.87M

EBITDA (USD)

FRX.TO EBITDA (USD) by year
Period	EBITDA (USD)
2025	-6.14M
2024	4.8M
2023	-12.44M
2022	-22.66M
2021	-17.22M
2020	-18.23M
2019	-12.99M
2018	-10.11M
2017	-6.77M
2016	-2.87M

Cash Flows (USD)

FRX.TO Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-14.55M
2024	26.98M
2023	-17.14M
2022	-18.06M
2021	-14.22M
2020	-15.6M
2019	-9.06M
2018	-7.83M
2017	-3.64M
2016	-2.12M

EPS (USD)

FRX.TO EPS (USD) by year
Period	EPS (USD)
2025	-0.34
2024	-0.07
2023	-0.61
2022	-0.91
2021	-0.66
2020	-0.76
2019	-0.64
2018	-0.52
2017	-0.44
2016	-0.22

Expenses (USD)

FRX.TO Expenses (USD) by year
Period	Expenses (USD)
2025	47.85M
2024	41.79M
2023	32.76M
2022	24.04M
2021	17.22M
2020	18.05M
2019	13.01M
2018	10.41M
2017	6.95M
2016	2.87M

Cash & Debt (USD)

FRX.TO Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	36.72M
2024	26.63M
2023	13.27M
2022	23.77M
2021	21.1M
2020	30.34M
2019	13.65M
2018	22.78M
2017	28.26M
2016	3.93M

Debt ratios

FRX.TO Debt ratios by year
Period	Debt ratios
2025	1.01
2024	0.15
2023	-0.25
2022	-0.02
2021	0.28
2020	0.63
2019	0.42
2018	1.05

Margins

FRX.TO Margins by year
Period	Margins
2025	91.55%
2024	93.3%
2023	94.08%
2022	87.39%
2020	100%

Return on Capital

FRX.TO Return on Capital by year
Period	Return on Capital
2025	-29.04%
2024	7.43%
2023	138.24%
2022	926.04%
2021	-109.98%
2020	-62.29%
2019	-107.58%
2018	-46.39%
2017	-26.33%
2016	-78.12%

Shares Outstanding

FRX.TO Shares Outstanding by year
Period	Shares Outstanding
2025	31.18M
2024	27.46M
2023	26.82M
2022	26.27M
2021	26.01M
2020	25.91M
2019	19.9M
2018	19.82M
2017	14.53M
2016	13.14M

Book Value Per Share (USD)

FRX.TO Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	1.12
2024	-0.21
2023	-0.43
2022	-0.1
2021	0.61
2020	1.12
2019	0.6
2018	1.08
2017	1.84
2016	0.27

Total Assets (USD)

FRX.TO Total Assets (USD) by year
Period	Total Assets (USD)
2025	70.07M
2024	44.95M
2023	26.86M
2022	26.94M
2021	22.41M
2020	31.42M
2019	14.15M
2018	22.95M
2017	28.4M
2016	3.97M

PE Ratio

FRX.TO PE Ratio by year
Period	PE Ratio
Dec 24	61.86
Dec 24	59.53
Dec 24	60.89
Dec 24	61.65
Nov 24	60.53
Nov 24	52.51
Nov 24	40.04
Nov 24	42.93
Nov 24	43.52
Oct 24	42.19
Oct 24	46.66
Oct 24	41.79
Oct 24	46.04
Sep 24	49.41
Sep 24	49.7
Sep 24	51.67
Sep 24	50.04
Aug 24	52.12
Aug 24	54.72
Aug 24	54.04
Aug 24	55.08
Aug 24	54.71
Jul 24	63.45
Jul 24	61.24
Jul 24	60.75
Jul 24	55.56

Free Cash Flow Yield

FRX.TO Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-1.85%
Sep 26	-1.82%
Aug 26	-1.87%
Aug 26	-2.03%
Aug 26	-1.87%
Aug 26	-1.99%
Jul 26	-2.32%
Jul 26	-2.27%
Jul 26	-2.26%
Jul 26	-2.24%
Jul 26	-2.12%
Jun 26	-4.35%
Jun 26	-5.21%
Jun 26	-5.27%
Jun 26	-5.12%
May 26	-4.71%
May 26	-4.71%
May 26	-4.82%
May 26	-6.62%
May 26	-7.15%
Apr 26	-6.82%
Apr 26	-6.8%
Apr 26	-7.98%
Apr 26	-7.28%
Mar 26	-4.77%
Mar 26	-3.89%
Mar 26	-3.66%
Mar 26	-3.75%
Feb 26	-3.35%
Feb 26	-3.26%
Feb 26	-3.71%
Feb 26	-3.63%
Jan 26	-3.82%
Jan 26	-3.75%
Jan 26	-3.79%
Jan 26	-3.67%
Jan 26	-3.78%
Dec 25	-3.68%
Dec 25	-3.8%
Dec 25	-3.72%
Dec 25	-3.75%
Nov 25	-3.58%
Nov 25	-3.59%
Nov 25	-3.6%
Nov 25	-5.07%
Oct 25	-5.1%
Oct 25	-4.66%
Oct 25	-5.11%
Oct 25	-4.81%
Oct 25	-4.28%
Sep 25	-6.57%
Sep 25	-6.86%
Sep 25	-6.44%
Sep 25	-6.62%
Aug 25	-6.6%
Aug 25	-6.88%
Aug 25	-6.93%
Aug 25	-7.17%
Aug 25	-7.44%
Jul 25	-6.79%
Jul 25	-7%
Jul 25	-6.72%
Jul 25	-6.64%
Jun 25	11.9%
Jun 25	12.53%
Jun 25	12.4%
Jun 25	11.41%
May 25	12%
May 25	12.1%
May 25	14.44%
May 25	15.14%
May 25	15.87%
Apr 25	19.22%
Apr 25	19.2%
Apr 25	19.32%
Apr 25	18.76%
Mar 25	13.43%
Mar 25	12.96%
Mar 25	13.1%
Mar 25	12.64%
Feb 25	12.32%
Feb 25	12.93%
Feb 25	12.51%
Feb 25	13.69%
Jan 25	13.5%
Jan 25	13.77%
Jan 25	15.68%
Jan 25	14.51%
Jan 25	14.14%
Dec 24	13.62%
Dec 24	14.15%
Dec 24	13.83%
Dec 24	13.66%
Nov 24	13.92%
Nov 24	16.04%
Nov 24	21.04%
Nov 24	19.62%
Nov 24	19.36%
Oct 24	19.97%
Oct 24	18.05%

Price to Sales

FRX.TO Price to Sales by year
Period	Price to Sales
Sep 26	8.31
Sep 26	8.45
Aug 26	8.21
Aug 26	7.55
Aug 26	8.23
Aug 26	7.71
Jul 26	6.63
Jul 26	6.77
Jul 26	6.81
Jul 26	6.88
Jul 26	7.24
Jun 26	7.47
Jun 26	6.23
Jun 26	6.16
Jun 26	6.34
May 26	6.89
May 26	6.89
May 26	6.73
May 26	4.9
May 26	4.54
Apr 26	4.76
Apr 26	4.77
Apr 26	4.07
Apr 26	4.46
Mar 26	4.31
Mar 26	5.29
Mar 26	5.62
Mar 26	5.49
Feb 26	6.14
Feb 26	6.32
Feb 26	5.55
Feb 26	5.68
Jan 26	5.39
Jan 26	5.49
Jan 26	5.43
Jan 26	5.61
Jan 26	5.45
Dec 25	5.59
Dec 25	5.41
Dec 25	5.53
Dec 25	5.49
Nov 25	5.75
Nov 25	5.74
Nov 25	5.72
Nov 25	6.92
Oct 25	6.88
Oct 25	7.52
Oct 25	6.87
Oct 25	7.3
Oct 25	8.19
Sep 25	8.07
Sep 25	7.73
Sep 25	8.24
Sep 25	8
Aug 25	8.03
Aug 25	7.71
Aug 25	7.65
Aug 25	7.39
Aug 25	7.12
Jul 25	7.81
Jul 25	7.57
Jul 25	7.89
Jul 25	7.98
Jun 25	4.77
Jun 25	4.53
Jun 25	4.58
Jun 25	4.98
May 25	4.73
May 25	4.69
May 25	3.93
May 25	3.75
May 25	3.58
Apr 25	2.95
Apr 25	2.96
Apr 25	2.94
Apr 25	3.03
Mar 25	3.56
Mar 25	3.69
Mar 25	3.65
Mar 25	3.78
Feb 25	3.88
Feb 25	3.7
Feb 25	3.82
Feb 25	3.49
Jan 25	3.54
Jan 25	3.47
Jan 25	3.05
Jan 25	3.3
Jan 25	3.38
Dec 24	3.46
Dec 24	3.33
Dec 24	3.41
Dec 24	3.45
Nov 24	3.39
Nov 24	2.94
Nov 24	2.24
Nov 24	2.4
Nov 24	2.43
Oct 24	2.36
Oct 24	2.61

EV/EBITDA

FRX.TO EV/EBITDA by year
Period	EV/EBITDA
Jun 25	45.72
Jun 25	43.37
Jun 25	43.83
Jun 25	47.78
May 25	45.36
May 25	44.97
May 25	37.41
May 25	35.62
May 25	33.91
Apr 25	27.74
Apr 25	27.77
Apr 25	27.59
Apr 25	28.45
Mar 25	44.91
Mar 25	46.62
Mar 25	46.09
Mar 25	47.85
Feb 25	49.14
Feb 25	46.72
Feb 25	48.39
Feb 25	44.02
Jan 25	44.68
Jan 25	43.74
Jan 25	38.14
Jan 25	41.42
Jan 25	42.55
Dec 24	21.12
Dec 24	20.27
Dec 24	20.77
Dec 24	21.05
Nov 24	20.64
Nov 24	17.7
Nov 24	13.14
Nov 24	14.2
Nov 24	14.42
Oct 24	13.93
Oct 24	15.56
Oct 24	13.78
Oct 24	15.34
Sep 24	16.45
Sep 24	16.56
Sep 24	17.32
Sep 24	16.69
Aug 24	17.5
Aug 24	18.5
Aug 24	18.24
Aug 24	18.64
Aug 24	18.5
Jul 24	21.89
Jul 24	21.03
Jul 24	20.84
Jul 24	18.83

Price/Operating Cashflow

FRX.TO Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Jun 25	8.4
Jun 25	7.98
Jun 25	8.07
Jun 25	8.77
May 25	8.34
May 25	8.27
May 25	6.92
May 25	6.61
May 25	6.3
Apr 25	5.2
Apr 25	5.21
Apr 25	5.18
Apr 25	5.33
Mar 25	7.45
Mar 25	7.72
Mar 25	7.63
Mar 25	7.91
Feb 25	8.11
Feb 25	7.73
Feb 25	8
Feb 25	7.31
Jan 25	7.41
Jan 25	7.26
Jan 25	6.38
Jan 25	6.89
Jan 25	7.07
Dec 24	7.34
Dec 24	7.07
Dec 24	7.23
Dec 24	7.32
Nov 24	7.19
Nov 24	6.23
Nov 24	4.75
Nov 24	5.1
Nov 24	5.17
Oct 24	5.01
Oct 24	5.54
Oct 24	4.96
Oct 24	5.46
Sep 24	5.11
Sep 24	5.14
Sep 24	5.35
Sep 24	5.18
Aug 24	5.39
Aug 24	5.66
Aug 24	5.59
Aug 24	5.7
Aug 24	5.66
Jul 24	6.57
Jul 24	6.34
Jul 24	6.29
Jul 24	5.75

Price to Book

FRX.TO Price to Book by year
Period	Price to Book
Sep 26	11.32
Sep 26	11.51
Aug 26	11.17
Aug 26	10.28
Aug 26	11.2
Aug 26	10.5
Jul 26	9.03
Jul 26	9.22
Jul 26	9.27
Jul 26	9.36
Jul 26	9.85
Jun 26	9.55
Jun 26	7.98
Jun 26	7.88
Jun 26	8.12
May 26	8.82
May 26	8.81
May 26	8.61
May 26	6.28
May 26	5.81
Apr 26	6.09
Apr 26	6.11
Apr 26	5.21
Apr 26	5.71
Sep 24	46.62
Sep 24	46.9
Sep 24	48.75
Sep 24	47.21
Aug 24	49.18
Aug 24	51.63
Aug 24	50.99
Aug 24	51.97
Aug 24	51.63
Jul 24	59.87
Jul 24	57.78
Jul 24	57.32
Jul 24	52.43
Mar 23	70.49
Mar 23	76.63
Mar 23	85.09
Mar 23	85.17
Feb 23	83.5
Feb 23	87.79
Feb 23	90.53
Feb 23	91.25
Jan 23	89.93
Jan 23	92.32
Jan 23	100.2
Jan 23	92.14
Dec 22	90.02
Dec 22	30.4
Dec 22	29.84
Dec 22	29.2
Dec 22	29.41
Nov 22	29.19
Nov 22	26.21
Nov 22	24.49
Nov 22	25.77
Oct 22	25.79
Oct 22	25.35
Oct 22	24.17
Oct 22	23.9
Sep 22	24.6
Sep 22	16.12
Sep 22	14.06
Sep 22	15.78
Sep 22	15.43
Aug 22	13.28
Aug 22	13.53
Aug 22	14.3
Aug 22	13.8
Jul 22	14.34
Jul 22	14.4
Jul 22	13.94
Jul 22	13.17
Jun 22	11.73
Jun 22	9.3
Jun 22	9.18
Jun 22	8.95
Jun 22	9.5
May 22	8.69
May 22	9.51
May 22	8.9
May 22	9.58
Apr 22	10.26
Apr 22	9.78
Apr 22	10.48
Apr 22	10.52
Apr 22	9.62
Mar 22	8.04
Mar 22	7.51
Mar 22	7.42
Mar 22	7.04
Feb 22	7.5
Feb 22	6.57
Feb 22	7.08
Feb 22	6.37
Jan 22	5.97
Jan 22	6.34
Jan 22	6.2

No video analysis for this stock yet. Request one from our team.

AI Analysis

Fennec Pharmaceuticals Inc.

Video analysis: FRX.TO

Similar companies